Suchergebnisse - "Hou, Yixuan J"

PubPharm (53)

1

A recombination-resistant genome for live attenuated and stable PEDV vaccines by engineering the transcriptional regulatory sequences

enthalten in: Journal of virology | 2023

von Niu, X. | Liu, M. | Yang, S. | +6

2

Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination

enthalten in: Cell host & microbe | 2023

von Munt, J. | Henein, S. | Adams, C. | +17

3

Host range, transmissibility and antigenicity of a pangolin coronavirus

enthalten in: Nature microbiology | 2023

von Hou, Y. | Chiba, S. | Leist, S. | +22

CommentIn: Nat Microbiol. 2023 Oct;8(10):1760-1761. - PMID 37749253

4

Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals

enthalten in: Journal of proteome research | 2023

von Fritch, E. | Mordant, A. | Gilbert, T. | +15

5

A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus

enthalten in: Science translational medicine | 2023

von Tse, L. | Hou, Y. | McFadden, E. | +15

6

A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levels

enthalten in: bioRxiv.org | 2023

von Markmann, A. | Bhowmik, D. | Jiang, B. | +6

7

A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levels

enthalten in: bioRxiv : the preprint server for biology | 2023

von Markmann, A. | Bhowmik, D. | Jiang, B. | +6

8

Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses

enthalten in: EBioMedicine | 2022

von Halfmann, P. | Frey, S. | Loeffler, K. | +9

9

Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients : CoronaVirus Inactivating Plasma (CoVIP) Study

enthalten in: mBio | 2022

von Bartelt, L. | Markmann, A. | Nelson, B. | +18

CommentIn: mBio. 2022 Oct 31;13(6):e0265322. - PMID 36314790

10

The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies

enthalten in: bioRxiv.org | 2022

von Premkumar, L. | Segovia-Chumbez, B. | Jadi, R. | +21

1
2
3
4
5
6
Nächster »
[6]